Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: Remedica Ltd., Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Rifaren 150 mg capsules.
Rifaren 300 mg capsules.
| Pharmaceutical Form |
|---|
|
Capsules. Rifaren 150 mg capsules: Red/Light blue capsules. Rifaren 300 mg capsules: Reddish brown/Reddish brown capsules. |
Rifaren 150 mg capsules:
Each Rifaren 150 mg capsule contains 150 mg rifampicin.
Rifaren 300 mg capsules:
Each Rifaren 300 mg capsule contains 300 mg rifampicin.
Excipients with known effect:
Rifaren 150 mg capsules:
Each Rifaren 150 mg capsule contains 60.9 mg lactose.
Rifaren 300 mg capsules:
Each Rifaren 300 mg capsule contains 101.46 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Rifampicin |
Rifampicin is an active bactericidial antituberculosis drug which is particularly active against the rapidly growing extracellular organisms and also has bactericidial activity intracellularly. Rifampicin inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. |
| List of Excipients |
|---|
Rifaren 150 mg tabletsCapsule content: Microcrystalline cellulose Capsule shell: Body: Indigo carmine E132 Cap: Erythrosine E127 Rifaren 300 mg tabletsCapsule content: Microcrystalline cellulose Capsule shell: Body: Erythrosine E127 Cap: Erythrosine E127 |
Rifaren 150 mg capsules:
PVC/Aluminium blisters. Pack-sizes of 20, 100 and 1000 capsules.
PP containers with PE closure. Pack-sizes of 100 and 1000 capsules.
Rifaren 300 mg capsules:
PVC/Aluminium blisters. Pack-sizes of 20, 100 and 1000 capsules.
PP containers with PE closure. Pack-sizes of 100 and 1000 capsules.
Not all pack-sizes may be marketed.
Remedica Ltd., Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Rifaren 150 mg capsules: 9029
Rifaren 300 mg capsules: 12369
Rifaren 150 mg capsules:
Date of first authorization: 15 September 1983
Date of latest renewal: 02 November 2009
Rifaren 300 mg capsules:
Date of first authorization: 06 July 1989
Date of latest renewal: 30 September 2011
| Drug | Countries | |
|---|---|---|
| RIFAREN | Cyprus, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
